INFUSYSTEM HOLDINGS, INC Increase (Decrease) in Derivative Assets and Liabilities
INFUSYSTEM HOLDINGS, INC (INFU) reported Increase (Decrease) in Derivative Assets and Liabilities of $365.00 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2012-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities · last filed 2012-03-16
- INFUSYSTEM HOLDINGS, INC increase (decrease) in derivative assets and liabilities for the quarter ending 2010-12-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in derivative assets and liabilities for the quarter ending 2010-09-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in derivative assets and liabilities for fiscal 2010 was $365.00K.
| Period end | Increase (Decrease) in Derivative Assets and Liabilities 3 month | Increase (Decrease) in Derivative Assets and Liabilities 6 month | Increase (Decrease) in Derivative Assets and Liabilities 9 month | Increase (Decrease) in Derivative Assets and Liabilities 12 month |
|---|---|---|---|---|
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $0.00 derived: sum of 2 quarters · filed 2012-03-16 | $365.00K 10-K · filed 2012-03-16 | |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $365.00K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $365.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |